Book Of Pharmaceutical Excipients Pdf
Liliane Hubright
Ideal properties of an excipientExcipients range from inert and simple to active and complex substances that can be difficult to characterize. Traditionally, excipients were often structurally simple, biologically inert, and of natural origin, such as corn, wheat, sugar, and minerals. Many more novel and increasingly complex excipients have been developed as novel drug formulation delivery systems emerge and evolve. The inert and innocuous nature of excipients is no longer a given feature in drug formulations. Many excipients are potential toxicants at high doses in animals, though safe in humans at therapeutic doses, including commonly used excipients such as cyclodextrins, dextran, and polyethylene glycol.
Apart from the physical and chemical properties it is important the excipients used are pharma grade excipients and comply with the current pharmacopeias such as Ph. Eur (European Pharmacopeia) , USP-NF (United States Pharmacopeia) and JP (Japanese Pharmacopeia). The pharmaceutical grade excipients production also requires the GMP level for excipients.
Oral solid dosage forms are still the majority of dosage forms in the pharmaceutical industry mainly driven by convenience of administration, stability, formulation, transport and other advantages over other forms such as injectables, topical, liquid or suppositories.
The site is secure.
The ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
This document provides guidance concerning development of safety profiles to support use of new excipients as components of drug or biological products. It is intended for use by reviewers within both the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) and by interested individuals in industry. It is also intended to foster and expedite the development of new excipients, communicate to pharmaceutical and excipient manufacturers current CDER and CBER recommendations on the nonclinical safety data that should be generated to support excipient development, and increase uniformity within CDER and CBER as to expectations for the nonclinical safety evaluation of excipients.
IPEC-Americas is the industry association that develops, implements, and promotes global use of appropriate quality, safety, and functionality standards for pharmaceutical excipients and excipient delivery systems. IPEC-Americas, along with our counterparts around the world, serves as the primary international resource on excipients for its members, governments and public audiences. read more...
The IPEC Foundation is the charitable arm of the International Pharmaceutical Excipients Council of the Americas and is a 501(c)3 organization. The Foundation awards grants-in-aid, travel, and meeting grants to qualified individuals and organizations for studying, instructing or conducting research related to improving excipients.
The IPEC Federation is an association that serves the interests of producers, distributors, and users of pharmaceutical excipients. Representatives from IPEC Americas, IPEC Europe, IPEC Japan, IPEC China, and IPEC India make up the council of IPEC whose global membership extends to more than 200 companies.
Carbopol polymers provide highly effective controlled-release properties for oral tablets at low usage levels, critical rheological and bioadhesive properties for topical formulations, and patient-centric benefits across multiple dosage forms.
In recent years, the landscape of pharmaceutical formulations has been witnessing a significant shift towards non-invasive delivery methods. Among these, nasal administration has emerged as a promising option, particularly in the wake of a respiratory virus pandemic and the quest for innovative drug delivery solutions. With a growing interest in nasal drug delivery, there's also a corresponding surge in products aiming to protect against respiratory infections.
Oral suspensions are pharmaceutical formulations in which solid particles of active ingredients are dispersed in a liquid vehicle. These suspensions are commonly used for administering medications to patients who have difficulty swallowing solid dosage forms, such as tablets or capsules, or for those who require customized dosages. Here's a comprehensive guide to understanding and formulating oral suspensions:
EXCiPACT is a non-profit organisation that owns and manages oversight of the independent, high quality, third-party Certification Scheme available to pharmaceutical excipient manufacturers and distributors worldwide.
Excipients are considered ingredients within a formulation with an Active Pharmaceutical Ingredient (API). Excipients ensure the conservation of the drug, but also can have an impact on the availability of the API itself. Ion exchange resins can be used as functional excipients. In addition to controlled released and taste masking applications, our ion exchange resin excipients have a broad range of uses from tablet disintegration and drug stability to abuse deterrence and solubility enhancement of poorly soluble drugs.
Our excipient solutions, with an extensive track record of innovation and reliable performance, are designed to help solve customer challenges and address some of the most pressing pharmaceutical trends.
Controlled release (CR) oral drug delivery systems are employed to improve patient compliance and therapeutic outcomes. Modified release (MR) dosage forms can be utilized to reduce the number of times the patient has to administer medication over the course of the day. They can also be utilized to prolong the time in which the systemic blood concentration remains within the therapeutic window, while avoiding potential adverse events from spikes in drug concentration.
DuPont Water Solutions offers a portfolio of functional polymeric ion exchange excipients, which are utilized to formulate various controlled release dosage forms like tablets, capsules, suspensions, and barrier-coated multiparticulates. Our strength is our commitment to quality and consistency. Our products are fully certified for pharmaceutical use and offer innovations for all kinds of drug delivery system designs.
Ion exchange resin excipients for orally disintegrating tablets and other dosage forms offer advantages over taste masking strategies. Limiting dissolution of API in the buccal cavity is an alternative that can be achieved via API-complexation using ion exchange resins. Additionally, DuPont has designed new equipment for buccal dissolution testing that allows the selection of taste masking formulations. This technology was speficially developed to help formulators optimize their taste masking formulations in vitro and show differences between formulations.
Controlled release solutions that deliver the active ingredient into the body at a specific rate and period Controlled release (CR) oral drug delivery systems are employed to improve patient compliance and therapeutic outcomes. Modified release (MR) dosage forms can be utilized to reduce the number of times the patient has to administer medication over the course of the day. They can also be utilized to prolong the time in which the systemic blood concentration remains within the therapeutic window, while avoiding potential adverse events from spikes in drug concentration.
Taste masking solutions to eliminate undesirable flavors for patients Ion exchange resin excipients for orally disintegrating tablets and other dosage forms offer advantages over taste masking strategies. Limiting dissolution of API in the buccal cavity is an alternative that can be achieved via API-complexation using ion exchange resins. Additionally, DuPont has designed new equipment for buccal dissolution testing that allows the selection of taste masking formulations. This technology was speficially developed to help formulators optimize their taste masking formulations in vitro and show differences between formulations.
Excipients have been defined in many ways, including as inert substances used as vehicles and diluents for drugs. The problem with this definition is that in recent years excipients have proved to be anything but inert, not only possessing the ability to react with other ingredients in the formulation, but also to cause adverse and hypersensitivity reactions in patients. These range from a mild rash to a potentially life-threatening reaction. Different brands of the same drug may contain different excipients, especially preservatives and colourants. The Consumer Medicines Information provides a list of excipients, and information on the safety of individual excipients can be found in drug reference guides.
The word excipient is derived from the Latin excipere, meaning 'to except', which is simply explained as 'other than'. Pharmaceutical excipients are basically everything other than the active pharmaceutical ingredient. Ideally, excipients should be inert, however, recent reports of adverse reactions have suggested otherwise.
The best new therapeutic entity in the world is of little value without an appropriate delivery system.1 Today, medicines are available in many dosage forms including tablets, capsules, oral liquids, topical creams and gels, transdermal patches, injectable products, implants, eye products, nasal products, inhalers and suppositories. Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability. They may also assist in product identification and enhance the overall safety or function of the product during storage or use.2
c80f0f1006